Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy, 11/05/09
Perichon B et al. – Competition growth experiments in the absence of inducer between the MRSA recipient and isogenic VRSA transconjugant revealed a disadvantage for the transconjugant, accounting, in part, for the low level of dissemination of the VRSA clinical isolates. The association of multiple molecular and environmental factors has been implicated in the regional emergence of VRSA in Michigan.
Related Articles
Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report
Pediatric Emergency Care, 10/29/09
Relevance Score: 69%
Staphylococcus aureus nasal carriage and its contributing factors
Future Microbiology, 11/05/09
Relevance Score: 68%
SpectraTM MRSA, A New Chromogenic Agar Medium to Screen for Methicillin-Resistant Staphylococcus aureus
Journal of Clinical Microbiology, 11/13/09
Relevance Score: 67%
Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus
Central European Journal of Medicine, 10/30/09
Relevance Score: 67%
Efficacy of a swab transport system in maintaining long-term viability of Staphylococcus aureus
Diagnostic Microbiology and Infectious Disease, 10/22/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Article Search
Sponsor


See Latest Articles


